Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KETO-CARE: Ketogenic Diet with Chemotherapy in Breast Cancer
NCT03535701Phase 1Completed
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Oct 2017
- Primary completion
- Mar 2020
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (2 arms), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Primary endpoints: Adherence and compliance to the ketogenic diet at 26 weeks, Changes in psychosocial measures at 26 weeks and 1 more. Started Oct 2017; status: completed.
Beyond the preview
Go deeper on NCT03535701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03535701.